IE913350A1 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- IE913350A1 IE913350A1 IE335091A IE335091A IE913350A1 IE 913350 A1 IE913350 A1 IE 913350A1 IE 335091 A IE335091 A IE 335091A IE 335091 A IE335091 A IE 335091A IE 913350 A1 IE913350 A1 IE 913350A1
- Authority
- IE
- Ireland
- Prior art keywords
- group
- formula
- cyclopropylmethyl
- compound
- xanthine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909020959A GB9020959D0 (en) | 1990-09-26 | 1990-09-26 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
IE913350A1 true IE913350A1 (en) | 1992-04-08 |
Family
ID=10682788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE335091A IE913350A1 (en) | 1990-09-26 | 1991-09-24 | Novel compounds |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0550570A1 (es) |
JP (1) | JPH06501251A (es) |
KR (1) | KR930702351A (es) |
AU (1) | AU653364B2 (es) |
CA (1) | CA2092430A1 (es) |
GB (1) | GB9020959D0 (es) |
IE (1) | IE913350A1 (es) |
MX (1) | MX9101237A (es) |
NZ (1) | NZ239921A (es) |
PT (1) | PT99062A (es) |
WO (1) | WO1992005175A1 (es) |
ZA (1) | ZA917610B (es) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0563168B1 (en) * | 1990-12-21 | 2000-07-05 | Beecham Group Plc | Xanthine derivatives |
GB9210839D0 (en) * | 1992-05-21 | 1992-07-08 | Smithkline Beecham Plc | Novel compounds |
US5817662A (en) * | 1992-11-09 | 1998-10-06 | Cell Therapeutics, Inc. | Substituted amino alkyl compounds |
US5646156A (en) * | 1994-04-25 | 1997-07-08 | Merck & Co., Inc. | Inhibition of eosinophil activation through A3 adenosine receptor antagonism |
AU4527896A (en) * | 1994-12-13 | 1996-07-03 | Euro-Celtique S.A. | Aryl thioxanthines |
JPH11505241A (ja) * | 1995-05-19 | 1999-05-18 | カイロサイエンス・リミテッド | キサンチン類およびこれらの治療的使用 |
MA24682A1 (fr) * | 1997-10-23 | 1999-07-01 | Smithkline Beecham Corp | Formes polymorphes nouvelles de cipamfylline, procede pour leur preparation et compositions les contenant |
AU6895801A (en) * | 2000-07-04 | 2002-01-14 | Novo Nordisk As | Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv |
ES2244634T3 (es) * | 2000-07-04 | 2005-12-16 | Novo Nordisk A/S | Purina-2,6-dionas como inhibidoras de la enzima dipeptidil peptidasa iv (ddp-iv). |
US6821978B2 (en) | 2000-09-19 | 2004-11-23 | Schering Corporation | Xanthine phosphodiesterase V inhibitors |
AR036674A1 (es) | 2001-08-28 | 2004-09-29 | Schering Corp | Inhibidores de fosfodiesterasa v de guanina de policiclicos, composicion farmaceutica, y el uso de dichos compuestos para la preparacion de medicamentos para tratar desordenes fisiologicos |
JP2005509038A (ja) | 2001-11-09 | 2005-04-07 | シェーリング コーポレイション | 多環式グアニン誘導体ホスホジエステラーゼv阻害剤 |
SI1509525T1 (sl) | 2002-05-31 | 2006-12-31 | Schering Corp | Postopek priprave inhibitorjev ksantinske fosfodiesteraze V in njihovih prekurzorjev |
AU2003231805A1 (en) | 2002-06-17 | 2004-02-09 | Glaxo Group Limited | Purine derivatives as liver x receptor agonists |
US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
MXPA06001195A (es) | 2003-07-31 | 2006-04-11 | Schering Corp | Metabolito de inhibidor de xantina fosfodiesterasa 5 y derivados del mismo utiles para el tratamiento de la disfuncion erectil. |
WO2005058898A2 (en) * | 2003-12-16 | 2005-06-30 | Ranbaxy Laboratories Limited | Purine compounds which can be used as phosphodiesterase (pde) type iv inhibitors |
US7501426B2 (en) | 2004-02-18 | 2009-03-10 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
DE102004030502A1 (de) | 2004-06-24 | 2006-01-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel |
DE102004037554A1 (de) | 2004-08-03 | 2006-03-16 | Sanofi-Aventis Deutschland Gmbh | Substituierte 8-Aminoalkylthio-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE102004039507A1 (de) | 2004-08-14 | 2006-03-02 | Sanofi-Aventis Deutschland Gmbh | Substituierte 8-Aminoalkoxi-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
DE102005035891A1 (de) | 2005-07-30 | 2007-02-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
CA2810839A1 (en) | 2006-05-04 | 2007-11-15 | Boehringer Ingelheim International Gmbh | A polymorphic form of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(r)-amino-piperidin-1-yl)-xanthine |
PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
AR071175A1 (es) | 2008-04-03 | 2010-06-02 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante |
KR20190016601A (ko) | 2008-08-06 | 2019-02-18 | 베링거 인겔하임 인터내셔날 게엠베하 | 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료 |
UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
RU2011113823A (ru) | 2008-09-10 | 2012-10-20 | БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) | Комбинированная терапия, предназначенная для лечения диабета и связанных с ним состояний |
US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
CN107011345A (zh) | 2008-12-23 | 2017-08-04 | 勃林格殷格翰国际有限公司 | 有机化合物的盐形式 |
AR074990A1 (es) | 2009-01-07 | 2011-03-02 | Boehringer Ingelheim Int | Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina |
KR20210033559A (ko) | 2009-11-27 | 2021-03-26 | 베링거 인겔하임 인터내셔날 게엠베하 | 리나글립틴과 같은 dpp-iv 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료 |
EP2566469B1 (en) | 2010-05-05 | 2022-12-21 | Boehringer Ingelheim International GmbH | Combination therapy |
EP2585101A1 (en) | 2010-06-24 | 2013-05-01 | Boehringer Ingelheim International GmbH | Diabetes therapy |
US9034883B2 (en) | 2010-11-15 | 2015-05-19 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
US8962636B2 (en) | 2011-07-15 | 2015-02-24 | Boehringer Ingelheim International Gmbh | Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
WO2013171167A1 (en) | 2012-05-14 | 2013-11-21 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome |
WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
JP6615109B2 (ja) | 2014-02-28 | 2019-12-04 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Dpp−4阻害薬の医学的使用 |
CN109310697A (zh) | 2016-06-10 | 2019-02-05 | 勃林格殷格翰国际有限公司 | 利格列汀和二甲双胍的组合 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988005775A1 (en) * | 1987-01-30 | 1988-08-11 | Sandoz-Erfindungen Verwaltungsgesellschaft M.B.H. | Novel xanthine derivatives |
GB8826595D0 (en) * | 1988-11-14 | 1988-12-21 | Beecham Wuelfing Gmbh & Co Kg | Active compounds |
GB8906792D0 (en) * | 1989-03-23 | 1989-05-10 | Beecham Wuelfing Gmbh & Co Kg | Treatment and compounds |
GB9020921D0 (en) * | 1990-09-26 | 1990-11-07 | Beecham Group Plc | Novel compounds |
WO1992007852A1 (en) * | 1990-10-25 | 1992-05-14 | G.D. Searle & Co. | Biphenylalkyl xanthine compounds for treatment of cardiovascular disorders |
-
1990
- 1990-09-26 GB GB909020959A patent/GB9020959D0/en active Pending
-
1991
- 1991-09-23 JP JP3515543A patent/JPH06501251A/ja active Pending
- 1991-09-23 CA CA002092430A patent/CA2092430A1/en not_active Abandoned
- 1991-09-23 EP EP91917224A patent/EP0550570A1/en not_active Withdrawn
- 1991-09-23 KR KR1019930700919A patent/KR930702351A/ko not_active Application Discontinuation
- 1991-09-23 WO PCT/GB1991/001633 patent/WO1992005175A1/en not_active Application Discontinuation
- 1991-09-23 AU AU85413/91A patent/AU653364B2/en not_active Ceased
- 1991-09-24 NZ NZ239921A patent/NZ239921A/xx unknown
- 1991-09-24 MX MX9101237A patent/MX9101237A/es not_active IP Right Cessation
- 1991-09-24 ZA ZA917610A patent/ZA917610B/xx unknown
- 1991-09-24 IE IE335091A patent/IE913350A1/en unknown
- 1991-09-25 PT PT99062A patent/PT99062A/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU653364B2 (en) | 1994-09-29 |
PT99062A (pt) | 1992-08-31 |
ZA917610B (en) | 1992-09-30 |
AU8541391A (en) | 1992-04-15 |
JPH06501251A (ja) | 1994-02-10 |
MX9101237A (es) | 1992-05-04 |
EP0550570A1 (en) | 1993-07-14 |
WO1992005175A1 (en) | 1992-04-02 |
KR930702351A (ko) | 1993-09-08 |
GB9020959D0 (en) | 1990-11-07 |
NZ239921A (en) | 1993-12-23 |
CA2092430A1 (en) | 1992-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU653364B2 (en) | Xanthine derivatives | |
AU649091B2 (en) | Xanthine derivatives | |
US5981535A (en) | Substituted xanthines and their use in the treatment of cerebrovascular disorders and other diseases | |
AU683270B2 (en) | Novel chemical compounds having PDE-IV inhibition activity | |
EP0163599B1 (en) | Pyrimidopyrimidine derivatives, processes for producing them, pharmaceutical compositions containing them and their use as anti-allergic agents | |
CS203093B2 (en) | Method of preparing substituted purines | |
EP0641344A1 (en) | 8-substituted anthines as phosphodiesterase inhibitors | |
AU650679B2 (en) | Xanthines | |
JPS63297381A (ja) | 9−〔2−(ヒドロキシメチル)シクロアルキルメチル〕グアニン類 | |
EP0243311B1 (en) | Pyrido[2,3-d]pyrimidine derivatives | |
EP0244352B1 (en) | Pyrido[4,3-d]pyrimidine derivatives | |
NO145404B (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme purinforbindelser og salter derav | |
MXPA99003958A (es) | Derivados de naftiridina |